Bioworld Financial Watch articles from November 2003

Bioworld Financial Watch archives from November 2003

Raptiva enters, Amevive slows: Enbrel maintains psoriasis grip.
November 3, 2003... Yet another drug, this one being Raptiva (efalizumab) from Genentech Inc., entered the psoriasis market last week, further testing the notion that any company itching for a piece of the action might find a place, if its drug is worthy enough to...

Collaborations between biotechnology companies and universities/nonprofit institutions: July 16 - Oct. 30, 2003.
November 3, 2003... Collaborations Between Biotechnology Companies And Universities/Nonprofit Institutions: July 16 - Oct. 30, 2003 Company * University/ Type Of (Country; Symbol) Non-Profit (@) Agreement Aclara...

BioWorld stock report for public biotechnology companies.
November 3, 2003... BioWorld Stock Report For Public Biotechnology Companies Close Close Company Symbol 10/24 10/31 Aastrom Biosci ASTM 1.46 1.26 Abgenix ABGX ...

Journal embargoes, news wording can cause trouble for companies.
November 10, 2003... Wall Street, sometimes, just doesn't get it. Contrary to what is often called the "increasing sophistication of biotechnology investors," stock prices that publicly held companies live by can react in strange and painful ways to news that...

Public financing of biotechnology: October 2003.
November 10, 2003... Public Financing Of Biotechnology: October 2003 I. COMMENCED TRADING IN OCTOBER Company Date Date Shares/ Price Shares (Symbol) Filed Comm. Units Out ...

Other financings of public biotechnology companies: October 2003.
November 10, 2003... Other Financings Of Public Biotechnology Companies: October 2003 TOTAL $354.88M Company Type Of Number Of Amount (Symbol) (#) Financing Shares, Units Raised ...

Venture capital and corporate investments in biotechnology companies: October 2003.
November 10, 2003... Venture Capital And Corporate Investments In Biotechnology Companies: October 2003 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $379.25M Company Location Date Amt. (M) Arrow London...

BioWorld stock report for public biotechnology companies.
November 10, 2003... BioWorld Stock Report For Public Biotechnology Companies %Change Company Symbol Close Close Vol 10/31 11/7 WK YTD...

Mighty Rituxan rules NHL roost as Amgen weighs new treatment.
November 17, 2003... If it's broke, don't fix it. That is, if the drug doesn't work as a monotherapy, then give up and try to find someone else who wants to take over development. Such was the eminently practical approach taken last week by Amgen Inc. with...

Clinical trials update: October 2003.
November 17, 2003... Clinical Trials Update: October 2003 Company * Product Description Indication (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel Etanercept; Rheumatoid (AMGN) (FDA-approved)...

Non-U.S. clinical trials, regulatory submissions, recommendations and approvals: October 2003.
November 17, 2003... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: October 2003 Company * (Country; Symbol) Product Description AUTOIMMUNE Centocor Inc. Remicade ...

FDA submissions, approvals and other actions: September 2003.
November 17, 2003... FDA Submissions, Approvals And Other Actions: September 2003 Company * (Country; Symbol) Product Description AUTOIMMUNE Amgen Inc. Enbrel Etanercept; (AMGN) and Wyeth ...

BioWorld stock report for public biotechnology companies.
November 17, 2003... BioWorld Stock Report For Public Biotechnology Companies Close Close Company Symbol 11/7 11/14 Aastrom Biosci ASTM 1.38 1.31 Abgenix ABGX ...

AMD race: eyetech drug falters, challengers will face Visudyne.
November 24, 2003... Age-related macular degeneration (AMD) is a demon of the elderly, snatching away their sight at a time in life when, for many, to watch the world is one of the great pleasures--a pleasure not afforded them in the busy, earlier years. And...

10 biggest U.S. gainers for the week.
November 24, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Applied Molecular 40.43 Palatin Tech 34.55 Pharsight 31.58 Large Scale 18.06 AutoImmune 16.33 Dyax 15.61 NeoPharm ...

10 biggest U.S. losers for the week.
November 24, 2003... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) V.I. Technol -73.53 Immtech -56.25 Cygnus -52.67 Biopure -25.44 Columbia Labs -20.31 Epimmune -20.19 Incara Pharma...

Biotech--big pharma collaborations: new agreements, Sept. 25-Nov. 20, 2003 (#).
November 24, 2003... Biotech -- Big Pharma Collaborations: New Agreements, Sept. 25 - Nov. 20, 2003 (#) Biotech Co. * Pharma Co. Type/Product Area (Country; (Country) Symbol) Abgenix Inc. AstraZeneca plc ...

Manufacturing, marketing and distribution agreements between Biotech and Pharmaceutical companies: Sept. 25-Nov. 20, 2003 (#).
November 24, 2003... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Sept. 25-Nov. 20, 2003 (#) Biotech Co. * Pharma Co. Product (Country; (Country) Symbol) Acorda ...

Biotech--big pharma collaborations: modified and terminated agreements, Sept. 25-Nov. 20, 2003 (#).
November 24, 2003... Biotech--Big Pharma Collaborations: Modified And Terminated Agreements, Sept. 25-Nov. 20, 2003 (#) I. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. Change from original (Country; (Country) ...

BioWorld stock report for public biotechnology companies.
November 24, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close 11/14 11/21 Aastrom Biosci ASTM 1.31 1.33 Abgenix ABGX 11.59 ...